Despite advancements in guideline-directed therapy, heart failure readmissions remain high. At the American College of Physicians Internal Medicine Meeting 2025, Shudhanshu Alishetti, MD, outlined how...
Recent updates in endocrinology reveal fezolinetant as a promising non-hormonal treatment for menopausal symptoms and tirzepatide’s impressive 93% risk reduction in progression from prediabetes to type 2...
A recent presentation at the American College of Physicians Internal Medicine Meeting 2025 highlighted updated approaches to inpatient diabetes management.
Biologic therapies have revolutionized the treatment of inflammatory arthritis, but their complexity demands practical understanding from clinicians across specialties.
